摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N1-tert-butoxycarbonyl-N3-(2-cyanoethyl)-1,3-propanediamine | 181780-44-9

中文名称
——
中文别名
——
英文名称
N1-tert-butoxycarbonyl-N3-(2-cyanoethyl)-1,3-propanediamine
英文别名
tert-butyl 3-(2-cyanoethylamino)propylcarbamate;tert-butyl N-[3-(2-cyanoethylamino)propyl]carbamate
N<sup>1</sup>-tert-butoxycarbonyl-N<sup>3</sup>-(2-cyanoethyl)-1,3-propanediamine化学式
CAS
181780-44-9
化学式
C11H21N3O2
mdl
——
分子量
227.307
InChiKey
CEHZXSOSSOLLLS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    389.3±27.0 °C(Predicted)
  • 密度:
    1.011±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    16
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.82
  • 拓扑面积:
    74.2
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Efficient Synthesis of Orthogonally Protected Spermidine and Norspermidine Derivatives
    作者:Ryszard Andruszkiewicz、Michał Radowski、Zbigniew Czajgucki
    DOI:10.1081/scc-200054211
    日期:2005.4.1
    Abstract Several orthogonally protected spermidine and norspermidine derivatives have been synthesized via cyanoethylation of monoprotected 1,4‐butanediamine (putrescine) or 1,3‐propanediamine followed by protection of their secondary amino groups and final reduction of the nitriles with lithium aluminum hydride in etheral solution at 0°C, thus affording protected norspermidine or spermidine that may
    摘要 通过单保护的 1,4-丁二胺(腐胺)或 1,3-丙二胺的氰乙基化,然后保护它们的仲氨基,最后在醚溶液中用氢化铝锂还原腈类,合成了几种正交保护的亚精胺和去甲精胺衍生物。在0°C,从而提供可用于合成多胺酰胺或可进一步官能化的受保护的去甲精胺或亚精胺。
  • Design and Synthesis of [2-(8,9-Dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)- ethyl]phosphonic Acid (EAA-090), a Potent <i>N</i>-Methyl-<scp>d</scp>-aspartate Antagonist, via the Use of 3-Cyclobutene-1,2-dione as an Achiral α-Amino Acid Bioisostere
    作者:William A. Kinney、Magid Abou-Gharbia、Deanna T. Garrison、Jean Schmid、Dianne M. Kowal、Donna R. Bramlett、Tracy L. Miller、Rene P. Tasse、Margaret M. Zaleska、John A. Moyer
    DOI:10.1021/jm970504g
    日期:1998.1.1
    that the two-carbon side chain length was optimum for NMDA receptor affinity. Substitution on the ring was found to be counterproductive in the case of sterically demanding dimethyl groups and of no consequence in the case of an H-bonding hydroxyl group. Replacement of the phosphonic acid group by either a carboxylic acid or a tetrazole group was unproductive. The potent bicyclic NMDA antagonists were
    二氮杂双环氨基酸膦酸酯15 [2-(8,9-dioxo-2,6-diazabicyclo [5.2.0] non-1(7)-en-2-yl)ethyl]膦酸被确定为有效的NMDA拮抗剂。它包含α-氨基酸生物甾体3,4-二氨基-3-环丁烯-1,2-二酮和一个用于构象刚性的附加环。在[3H] CPP结合测定,受激[3H] TCP结合测定和NMDA诱导的小鼠致死性模型中,化合物15与CGS-19755(5)一样有效。在大鼠大脑中动脉永久闭塞后,静脉内单次推注剂量的化合物15使梗塞组织的大小减少了57%。结构-活性关系(SAR)研究表明六元和八元环衍生物的活性降低,并且两个碳的侧链长度最适合NMDA受体的亲和力。发现在空间上需要二甲基的情况下,环上的取代会适得其反,而在氢键结合的羟基的情况下则无济于事。用羧酸或四唑基团取代膦酸基是无用的。有效的双环NMDA拮抗剂有效地合成了他们的非手性性质和容易从
  • Facile Synthetic Route to Selectively Protected Spermidine Homologues
    作者:Ryszard Andruszkiewicz、Ewa Gronek、Jolanta Hałuszczak
    DOI:10.1080/00397910701845431
    日期:2008.2.1
    Abstract Several selectively protected spermidine homologues were synthesized via cyanoethylation reaction of monoprotected diamines, subsequent protection of their secondary amino group, hydrolysis of nitrile to primary amide function, and final Hofmann degradation of amides to amines with the aid of iodosobenzene diacetate (PIDA). The protected spermidine homologues may be directly used in the synthesis
    摘要 通过单保护二胺的氰乙基化反应、仲氨基的后续保护、腈水解为伯酰胺官能团以及酰胺在二乙酸碘苯酯 (PIDA) 的帮助下最终霍夫曼降解为胺,合成了几种选择性保护的亚精胺同系物。受保护的亚精胺同系物可直接用于多胺酰胺的合成或可进一步官能化。
  • Arasujo, M. Joso S. M. P.; Ragnarsson, Ulf; Trigo, M. Joaquina S. A. Amaral, Journal of Chemical Research, Miniprint, 1996, # 8, p. 2143 - 2161
    作者:Arasujo, M. Joso S. M. P.、Ragnarsson, Ulf、Trigo, M. Joaquina S. A. Amaral、Almeida, M. Lurdes S.
    DOI:——
    日期:——
  • Polyaminoquinoline Iron Chelators for Vectorization of Antiproliferative Agents: Design, Synthesis, and Validation
    作者:Vincent Corcé、Emmanuelle Morin、Solène Guihéneuf、Eric Renault、Stéphanie Renaud、Isabelle Cannie、Raphaël Tripier、Luís M. P. Lima、Karine Julienne、Sébastien G. Gouin、Olivier Loréal、David Deniaud、François Gaboriau
    DOI:10.1021/bc300324c
    日期:2012.9.19
    Iron chelation in tumoral cells has been reported as potentially useful during antitumoral treatment. Our aim was to develop new polyaminoquinoline iron chelators targeting tumoral cells. For this purpose, we designed, synthesized, and evaluated the biological activity of a new generation of iron chelators, which we named Quilamines, based on an 8-hydroxyquinoline (8-HQ) scaffold linked to linear polyamine vectors. These were designed to target tumor cells expressing an overactive polyamine transport system (PTS). A set of Quilamines bearing variable polyamine chains was designed and assessed for their ability to interact with iron. Quilamines were also screened for their cytostatic/cytotoxic effects and their selective uptake by the PTS in the CHO cell line. Our results show that both the 8-HQ moiety and the polyamine part participate in the iron coordination. HQ1-44, the most promising Quilamine identified, presents a homospermidine moiety and was shown to be highly taken up by the PTS and to display an efficient antiproliferative activity that occurred in the micromolar range. In addition, cytotoxicity was only observed at concentrations higher than 100 mu M. We also demonstrated the high complexation capacity of HQ1-44 with iron while much weaker complexes were formed with other cations, indicative of a high selectivity. We applied the density functional theory to study the binding energy and the electronic structure of prototypical iron(III)-Quilamine complexes. On the basis of these calculations, Quilamine HQ1-44 is a strong tridentate ligand for iron(III) especially in the form of a 1:2 complex.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物